Exagen Inc. (XGN)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$2.72
-0.91%
Mkt Cap $76.60M
Analyst Ratings
No recent rating data.
Price Target (9 analysts)
$13.00
Range $9.00 – $15.00
Implied Upside
+378.8%
Consensus $13.00 vs current $2.72
NASDAQ·Healthcare·Medical - Diagnostics & Research
$2.72
-0.91%
Mkt Cap $76.60M
No recent rating data.
Price Target (9 analysts)
$13.00
Range $9.00 – $15.00
+378.8%
Consensus $13.00 vs current $2.72